New Liquid Biopsy Technologies to Know. Part 3 with Dennis Merkle, CEO of Predicine Europe.

Adam Hargreaves By Adam Hargreaves

In the final part of this three-part episode, Dennis and I discuss new technologies to watch in the liquid biopsy market, as well as insights into innovation from behind the scenes at Predicine.

Dennis touches on how to become a legendary company in your market, and what this means in liquid biopsy terms. A truly eye-opening discussion which anyone would be sure to gain something from.

In parts one and two, we discussed the importance of liquid biopsy for the future oncology market as well as strategies for overcoming barriers when entering new markets. A huge thanks to Dennis for coming on to share his knowledge and experience.

If you'd like to get in touch about this episode, be a future podcast guest, or learn more about CM Life Science's services, please email me at adam.hargeaves@lifesci-cm.com.

Recommended.